FLUIDIA is a start-up that develops and commercializes a new generation of molecular tests to diagnose different types of diseases. The new technology that FLUIDIA has developed and patented makes it possible to evaluate the shape of any biomarker protein quickly and economically. The start-up has applied this innovative technology to a biomarker common to the main cancers, thus making it possible to develop an early detection test that will be introduced on the market in 2020.

Website : www.fluidiabiotech.com

Call 2018

The 2018 call for applications for the Young Enterprise Initiative – Start in France is now closed for Finnish, Italian, South Korean, Taiwanese, and U.S. companies. The call will open soon for South African companies.

Country Programs



Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links